Daratumumab in Immune-mediated Thrombotic Thrombocytopenic Purpura

Clinical trial NCT07513948 · RECRUITING

Trial details

NCT number: NCT07513948
Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Status: RECRUITING
Study type: OBSERVATIONAL

Thrombotic Thrombocytopenic Purpura, Acquired

Start date: 2025-10-01
Primary completion: 2026-06-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.